The General Office of the People's Government of Inner Mongolia Autonomous Region recently issued the “Inner Mongolia Autonomous Region Action Plan to Accelerate the High-Quality Development of the Biomantry Industry”. Among them, it is proposed to enhance the core competitiveness of biomedicine. Accelerate the construction and operation of platforms such as the Hohhot Biointelligence Valley, focus on new characteristic tracks such as nucleic acid drugs, cell and gene therapy, and “AI+ medicine”, and push the biomedical industry to leap from scale advantage to technological leadership. Consolidate and enhance the leading position in the global market for animal vaccine products such as the foot-and-mouth disease vaccine, accelerate the development of the African swine fever vaccine, strengthen the promotion and application of novel vaccines and multi-valent vaccines in the region, and enhance prevention and control capabilities for major animal diseases. Give full play to the platform advantages of the company's P3 laboratory, accelerate the development and industrialization process of cutting-edge products such as mRNA vaccines and mucosal administration vaccines, and build the world's leading intelligent manufacturing benchmark for animal vaccines. Deepen the secondary development of traditional Chinese medicine, use synthetic biotechnology to enable the discovery and efficient preparation of functional components of characteristic Chinese herbal medicines, and build a modern traditional Chinese medicine industrial system with Inner Mongolian characteristics.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.